Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 3,211 | 5,242 | 3,638 | 3,572 | 3,258 |
| Operating Income | -3,211 | -5,242 | -3,638 | -3,572 | -3,258 |
| Other Income | 67 | 92 | 80 | 44 | 66 |
| Pre-tax Income | -3,144 | -5,150 | -3,558 | -3,528 | -3,192 |
| Net Income Continuous | -3,144 | -5,150 | -3,558 | -3,528 | -3,192 |
| Minority Interests | -4 | -30 | -27 | -16 | -18 |
| Net Income | $-3,140 | $-5,120 | $-3,531 | $-3,512 | $-3,174 |
| EPS Basic Total Ops | -47.50 | -77.50 | -57.50 | -62.50 | -330.00 |
| EPS Basic Continuous Ops | -46.94 | -76.61 | -54.02 | -56.33 | 134.93 |
| EPS Diluted Total Ops | -47.50 | -77.50 | -57.50 | -62.50 | -330.00 |
| EPS Diluted Continuous Ops | -46.94 | -76.61 | -54.02 | -56.33 | 134.93 |
| EBITDA(a) | $-3,153 | $-5,182 | $-3,578 | $-3,510 | $-3,193 |